RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. Repayments of term debt

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.2B
P/E ratio
SummaryFinancials
Period EndRepayments of term debt (Million USD)YoY (%)
Dec 31, 20248-97.41%
Dec 31, 2023319+17792.08%
Dec 31, 20222-95.15%
Dec 31, 202137+337.33%
Dec 31, 20208+30.57%
Dec 31, 20196+12.78%
Dec 31, 20186-41.26%
Dec 31, 201710-33.72%
Dec 31, 201615+62.96%
Dec 31, 20159+9.43%
Dec 31, 20148

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)